Browsing by Author Punt, Cornelis JA

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2014Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013Pavlakis, Nick; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos; Price, Timothy; Punt, Cornelis JA; Segelov, Eva; Shapiro, J; Tebbutt, Niall; Northern Clinical School: MedicineCurrent opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013, Expert Review of Anticancer Therapy, vol.14, 12, 2014,pp 1477-1493
2016Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseTebbutt, Niall; Adams, Richard; et al, Various; Franko, Jan; Koopman, Miriam; Maughan, Timothy; Meyers, Jeffrey; Punt, Cornelis JA; Saltz, Leonard B.; Seymour, Matthew; Shi, Qian; NH&MRC Clinical Trials CentrePrognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database, The Lancet Oncology, vol.17, 12, 2016,pp 1709-1719
2016Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015Gibbs, Peter; Thavaneswaran, Subotheni; Arnold, Dirk; Burge, Matthew; Haller, Daniel; Karapetis, Christos; Pavlakis, Nick; Price, Timothy; Punt, Cornelis JA; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreUpdate on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015, Expert Review of Anticancer Therapy, vol.16, 5, 2016,pp 557-571
2016Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015Gibbs, Peter; Thavaneswaran, Subotheni; Arnold, Dirk; Burge, Matthew; Haller, Daniel; Karapetis, Christos; Pavlakis, Nick; Price, Timothy; Punt, Cornelis JA; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreUpdate on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015, Expert Review of Anticancer Therapy, vol.16, 5, 2016,pp 557-571
2015Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancerByth Wilson, Karen; Cummins, Michelle; Lee, Chee Khoon; Simes, Robert John; Asadi, K; Chionh, F; Mariadason, John M; Murone, C; Nagtegaal, ID; Price, Timothy; Punt, Cornelis JA; Scott, Andrew M; Tebbutt, Niall; Weickhardt, Andrew J; Williams, DS; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreVascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer, British Journal of Cancer, vol.113, 1, 2015,pp 37-45